Skip to content
OpenCapital
Get started

Silexion Therapeutics SLXN Q1 2026 earnings

Reported May 15, 2026 · Before market open

EPS-$0.85Beat by $0.44
EPS estimate-$1.29

Next report

Aug 11, 2026 (In 1 week)
EPS estimate-$21.20

Versus estimates

Diluted EPS

Q1 2026-$0.85Beat by $0.44
Q4 2025-$2.39Miss by $1.21Q3 2025-$2.88Beat by $0.52Q2 2025-$4.32Miss by $1.17Q1 2025-$3.90Miss by $3.68Q4 2024-$20.76Miss by $19.78

Ask the moment Silexion Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Silexion Therapeutics report Q1 2026 earnings?
Silexion Therapeutics (SLXN) reported Q1 2026 earnings on May 15, 2026 before market open.
What were Silexion Therapeutics's Q1 2026 revenue and EPS?
Silexion Therapeutics reported eps of $-0.85 for Q1 2026.
Did Silexion Therapeutics beat estimates in Q1 2026?
EPS beat the consensus estimate of $-1.29 by $0.44.
How did Silexion Therapeutics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 78.2% from $-3.90.
Where can I find Silexion Therapeutics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001178913-26-002624) and the 10-Q periodic report (0001178913-26-002744) directly on SEC EDGAR. The filing index links above go to sec.gov.